Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2017-12-13 2017-12-13
Drug Identification Number 02041464 02041464
Brand name ATIVAN ATIVAN
Common or Proper name ATIVAN ATIVAN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LORAZEPAM LORAZEPAM
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration SUBLINGUAL SUBLINGUAL
Packaging size 1X100 TAB/BTL 1X100 TAB/BTL
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-12-14 2017-12-14
Actual start date
Estimated end date 2017-12-18 2017-12-18
Actual end date 2017-12-12 2017-12-12
Shortage status Avoided shortage Avoided shortage
Tier 3 Status No No
Company comments
Health Canada comments